Gradient Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Gradient Investments’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14	Closed	–	–	1364
2021 Q3	$0	Hold	14	–	–	﹤0.01%	1297
2021 Q2	$1K	Buy	+14	New	+$429	﹤0.01%	1133

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Gradient Investments's DRNA Position: Q4 2021 in Review

Gradient Investments sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 14 shares.

Gradient Investments first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Gradient Investments reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Gradient Investments sold 14 Dicerna Pharmaceuticals, Inc. shares in Q4 2021.
Gradient Investments first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Gradient Investments's Dicerna Pharmaceuticals, Inc. position peaked at $1K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Gradient Investments's 13F filing for Q4 2021, filed 12 Jan 2022.